Korea Investment Corp Teva Pharmaceutical Industries LTD Transaction History

Korea Investment Corp

$38.9 Billion
Q2 2024

A detailed history of Korea Investment Corp transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Korea Investment Corp holds 220,756 shares of TEVA stock, worth $3.86 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

220,756

Previous 224,456 1.65%

Holding current value

$3.86 Million

Previous $3.17 Million 13.26%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$12.78 - $17.4 $47,286 - $64,379	-3,700 Reduced 1.65%	220,756 $3.59 Million
Q1 2024 May 14, 2024	BUY	$10.67 - $14.43 $11,704 - $15,829	1,097 Added 0.49%	224,456 $3.17 Million
Q4 2023 Feb 13, 2024	BUY	$8.12 - $10.63 $210,925 - $276,124	25,976 Added 13.16%	223,359 $2.33 Million
Q3 2023 Nov 13, 2023	SELL	$7.48 - $10.7 $246,914 - $353,207	-33,010 Reduced 14.33%	197,383 $2.01 Million
Q2 2023 Aug 11, 2023	BUY	$7.2 - $9.47 $139,680 - $183,718	19,400 Added 9.19%	230,393 $1.73 Million
Q1 2023 May 12, 2023	SELL	$8.36 - $11.37 $429,578 - $584,247	-51,385 Reduced 19.58%	210,993 $1.87 Million
Q4 2022 Feb 13, 2023	SELL	$7.95 - $9.48 $37,237 - $44,404	-4,684 Reduced 1.75%	262,378 $2.39 Million
Q3 2022 Nov 10, 2022	BUY	$6.86 - $11.95 $541,679 - $943,595	78,962 Added 41.98%	267,062 $2.16 Million
Q2 2022 Aug 12, 2022	BUY	$7.38 - $10.4 $50,184 - $70,720	6,800 Added 3.75%	188,100 $1.42 Million
Q1 2022 May 13, 2022	BUY	$7.33 - $9.39 $353,306 - $452,598	48,200 Added 36.21%	181,300 $1.7 Million
Q4 2021 Feb 09, 2022	BUY	$7.9 - $10.19 $101,910 - $131,451	12,900 Added 10.73%	133,100 $1.07 Million
Q3 2021 Nov 12, 2021	SELL	$8.38 - $10.18 $44,414 - $53,954	-5,300 Reduced 4.22%	120,200 $1.17 Million
Q2 2021 Aug 12, 2021	BUY	$9.9 - $11.56 $195,030 - $227,732	19,700 Added 18.62%	125,500 $1.24 Million
Q1 2021 May 13, 2021	SELL	$10.34 - $12.81 $3.55 Million - $4.39 Million	-342,855 Reduced 76.42%	105,800 $1.22 Million
Q4 2020 Feb 10, 2021	SELL	$8.61 - $11.04 $440,832 - $565,248	-51,200 Reduced 10.24%	448,655 $4.33 Million
Q3 2020 Nov 12, 2020	SELL	$8.57 - $12.69 $7,713 - $11,421	-900 Reduced 0.18%	499,855 $4.5 Million
Q2 2020 Aug 12, 2020	SELL	$8.12 - $13.12 $1.1 Million - $1.77 Million	-135,200 Reduced 21.26%	500,755 $6.17 Million
Q1 2020 May 14, 2020	BUY	$6.69 - $13.45 $832,905 - $1.67 Million	124,500 Added 24.34%	635,955 $5.71 Million
Q4 2019 Feb 11, 2020	BUY	$6.53 - $10.72 $191,982 - $315,168	29,400 Added 6.1%	511,455 $5.01 Million
Q3 2019 Nov 12, 2019	BUY	$6.16 - $9.6 $55,440 - $86,400	9,000 Added 1.9%	482,055 $3.32 Million
Q2 2019 Aug 12, 2019	SELL	$8.12 - $15.72 $1.04 Million - $2.01 Million	-127,600 Reduced 21.24%	473,055 $4.37 Million
Q1 2019 May 15, 2019	BUY	$15.58 - $20.01 $373,920 - $480,240	24,000 Added 4.16%	600,655 $9.42 Million
Q4 2018 Feb 13, 2019	SELL	$14.59 - $23.84 $422,789 - $690,835	-28,978 Reduced 4.78%	576,655 $8.89 Million
Q3 2018 Nov 13, 2018	BUY	$21.06 - $25.65 $1.11 Million - $1.35 Million	52,600 Added 9.51%	605,633 $13 Million
Q2 2018 Aug 13, 2018	BUY	$16.77 - $24.71 $2.01 Million - $2.96 Million	119,900 Added 27.68%	553,033 $0
Q1 2018 May 09, 2018	BUY	$16.68 - $22.07 $3.06 Million - $4.05 Million	183,300 Added 73.37%	433,133 $7.4 Million
Q4 2017 Feb 12, 2018	BUY	$11.23 - $19.1 $56,812 - $96,626	5,059 Added 2.07%	249,833 $4.73 Million
Q3 2017 Oct 25, 2017	BUY	$15.41 - $32.17 $3.77 Million - $7.87 Million	244,774	244,774 $4.31 Million

Others Institutions Holding TEVA

# of Institutions

617

Shares Held

563M

Call Options Held

25.2M

Put Options Held

5.08M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

News

Stay updated on Korea Investment Corp with notifications on news.

Account

Korea Investment Corp Teva Pharmaceutical Industries LTD Transaction History